A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
Clinical trial NCT07700056 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07700056
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-14
- Primary completion
- 2029-12-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.